JXJianquan Xu

Jianquan Xu

*This is an algorithmically generated author record based on publicly available information.

Jianquan Xu has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Yang Liu

    Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA

    4 shared publications
  • Hongqiang Ma

    Biomedical and Optical Imaging Laboratory, Deparstments of Medicine and Bioengineering, University of Pittsburgh, Pittsburgh, USA

    2 shared publications
  • Xuejiao Sun

    University of Pittsburgh,Departments of Medicine and Bioengineering,Pittsburgh,PA,USA,15213

    2 shared publications
  • Anita P. Bargaje

    Division of Cardiology, Pediatric Institute for Heart Regeneration and Therapeutics (I-HRT), UPMC Children's Hospital of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA 15224, USA; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA

    1 shared publication
  • Bernhard Kühn

    Weill Cornell Medical College, Cornell University 1 Department of Pediatrics New York City, NY

    1 shared publication
  • Dhivyaa Rajasundaram

    Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA

    1 shared publication

Latest Publications

  • An integrated platform for mesoscale quantitative phase imaging and hyperplex fluorescence microscopy

    by Maomao Chen, Hongqiang Ma, Jianquan Xu, Xuejiao Sun, Yang Liu

    Quantitative phase microscopy is a powerful label-free imaging technique to assess morphology and architecture of biological cells and tissue. But its lack of molecular specificity often makes it difficult to assign specific subcellular structures and functional states. Here we combine quantitative phase imaging (QPI) with multiplex fluorescence microscopy at mesoscale that allow the simultaneous assessment of both morphological changes and their functional states over a field of view of a few millimeters at a sub-micron resolution. Further, quantitative phase images can also be used for automatic focusing and image registration, effectively overcoming the traditional hurdles posed by the markedly inconsistent fluorescence intensity encountered in various settings. This integrated system will serve as a vital instrument in understanding the molecular attributes and functional states underlying the morphological characteristics assessed quantitative phase imaging in spatial cell biology.

  • Changes in nuclear pore numbers control nuclear import and stress response of mouse hearts

    by Lu Han, Jocelyn D. Mich-Basso, Yao Li, Niyatie Ammanamanchi, Jianquan Xu, Anita P. Bargaje, Honghai Liu, Liwen Wu, Jong-Hyeon Jeong, Jonathan Franks, et al.


  • Open Access

    Ultrastructural visualization of chromatin in cancer pathogenesis using a simple small-molecule fluorescent probe

    by Jianquan Xu, Xuejiao Sun, Kwangho Kim, Rhonda M. Brand, Douglas Hartman, Hongqiang Ma, Randall E. Brand, Mingfeng Bai, Yang Liu

    Imaging chromatin organization at the molecular-scale resolution remains an important endeavor in basic and translational research. Stochastic optical reconstruction microscopy (STORM) is a powerful superresolution imaging technique to visualize nanoscale molecular organization down to the resolution of ~20 to 30 nm. Despite the substantial progress in imaging chromatin organization in cells and model systems, its routine application on assessing pathological tissue remains limited. It is, in part, hampered by the lack of simple labels that consistently generates high-quality STORM images on the highly processed clinical tissue. We developed a fast, simple, and robust small-molecule fluorescent probe—cyanine 5–conjugated Hoechst—for routine superresolution imaging of nanoscale nuclear architecture on clinical tissue. We demonstrated the biological and clinical significance of imaging superresolved chromatin structure in cancer development and its potential clinical utility for cancer risk stratification.


  • Open Access

    The amyloid precursor protein modulates the position and length of the axon initial segment offering a new perspective on Alzheimer’s disease genetics

    by Fulin Ma, Jianquan Xu, Yang Liu, Dina Popova, Mark M. Youssef, Ronald P. Hart, Karl Herrup

    The small Aβ peptide has been hypothesized to be the main driver of Alzheimer’s disease (AD). Aβ is a proteolytic cleavage product of a larger protein, the amyloid precursor protein (APP), whose normal functions remain largely unexplored. We report here activities of the full-length APP protein that relate directly to the etiology of AD. Increasing neuronal activity leads to a rapid increase in App gene expression. In both cultures of mouse cortical neurons and human iPSC-derived neurons, elevated APP protein changes the structure of the axon initial segment (AIS), the site of action potential initiation. In neurons with elevated APP, the AIS shortens in length and shifts in position away from the cell body. Both changes would be expected to reduce neuronal excitability. The AIS effects are due to the cell-autonomous actions of APP; exogenous Aβ – either fibrillar or oligomeric – has no effect. The findings relate directly to AD in several ways. In culture, APP carrying the Swedish familial AD mutation (APP Swe ) induces stronger AIS changes than wild type APP. Ankyrin G and βIV-spectrin, scaffolding proteins of the AIS, both physically associate with APP, and APP Swe binds more avidly than wild type APP. Finally, neurons in the frontal cortex of humans with sporadic AD reveal histologically elevated levels of APP protein that invade the domain of the AIS, whose length is significantly shorter than that found in healthy control neurons. The findings offer an alternative explanation for the effects of at least some familial AD mutations. Significance: In familial Alzheimer’s disease (AD) the linkage between the genetics of APP, the neuropathology of the amyloid plaques and the symptoms of dementia are one of the strongest pieces of evidence supporting the amyloid cascade hypothesis – a conceptualization that marks the Aβ peptide as the root cause of AD. Yet, formally, the genetics only point to APP, not its Aβ breakdown product. We report here that the full-length APP protein affects the properties of the axon initial segment and through these changes serves as a dynamic regulator of neuronal activity. We propose that this newly discovered APP function offers a different, Aβ-independent, view of the genetic evidence.